References: BofA Lifts Eli Lilly Target to $1,251 on Obesity Pill Momentum and Pipeline Strength Eli Lilly Jumps Over 5% as CVS Restores Zepbound Coverage, Adds Foundayo to Drug Plans Eli Lilly's RETA Achieves 28% Weight Loss in Phase 3 Trial, Rivaling Bariatric Surgery as Market Cap Nears $1 Trillion Obesity Drug Distributors Thrive: GC Biopharma, Chong Kun Dang Surge While Hanmi, Daewoong Struggle US Q1 GDP Revised Down to 1.6% Growth on Weaker Consumer Spending, Inventories Once added, BigGo Finance appears first in Google Search Top Stories, so you get the broadest, most up-to-the-minute, and most comprehensive global financial news first
Direct and indirect healthcare costs related to obesity are more than $1.7 trillion annually
It is prepared per prescription and can differ in form and concentration
Billing disputes, difficulty canceling, and unresponsive customer service appear most frequently
L-Carnitine may interact with certain anticoagulants, thyroid medications, and some chemotherapy agents
As millions cycle off GLP-1s, appetite often returns faster than confidence, creating a fragile moment where food choices are shaped as much by fear as by hunger
